P2RY8 variants in lupus patients uncover a role for the receptor in immunological tolerance
He Yuke, Gallman Antonia E., Xie Chengmei, Shen Qian, Ma Jianyang, Wolfreys Finn D., Sandy Moriah, Arsov Todor, Wu Xiaoqian, Qin Yuting, Zhang Pingjing, Jiang Simon, Stanley Maurice, Wu Philip, Tan Jingjing, Ding Huihua, Xue Haiyan, Chen Wei, Xu Jinping, Criswell Lindsey A., Nititham Joanne, Adamski Marcin, Kitching A. Richard, Cook Matthew C., Cao Lanfang, Shen Nan, Cyster Jason G., Vinuesa Carola G.
Journal:JOURNAL OF EXPERIMENTAL MEDICINE
IF:14.31
DOI:10.1084/jem.20211004
PMID:34889940
Published:2021-12-10
research field:
Abstract
B cell self-tolerance is maintained through multiple checkpoints, including restraints on intracellular signaling and cell trafficking. P2RY8 is a receptor with established roles in germinal center (GC) B cell migration inhibition and growth regulation. Somatic P2RY8 variants are common in GC-derived B cell lymphomas. Here, we identify germline novel or rare P2RY8 missense variants in lupus kindreds or the related antiphospholipid syndrome, including a “de novo” variant in a child with severe nephritis. All variants decreased protein expression, F-actin abundance, and GPCR-RhoA signaling, and those with stronger effects increased AKT and ERK activity and cell migration. Remarkably, P2RY8 was reduced in B cell subsets from some SLE patients lacking P2RY8 gene variants. Low P2RY8 correlated with lupus nephritis and increased age-associated B cells and plasma cells. By contrast, P2RY8 overexpression in cells and mice restrained plasma cell development and reinforced negative selection of DNA-reactive developing B cells. These findings uncover a role of P2RY8 in immunological tolerance and lupus pathogenesis.
本文使用的Yeasen产品


